These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2569320

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Pharmacology aspects of glaucoma].
    Alm A, Berggren L.
    Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G, Carreiro S, Anderson S, Gukasyan H, Sartnurak S, Younis H, Gale D, Xiang C, Wells P, Dinh D, Almaden C, Fortner J, Toris C, Niesman M, Lafontaine J, Krauss A.
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The impact of glaucoma medication on parameters of ocular perfusion.
    Harris A, Jonescu-Cuypers CP.
    Curr Opin Ophthalmol; 2001 Apr; 12(2):131-7. PubMed ID: 11224720
    [Abstract] [Full Text] [Related]

  • 30. [New developments in drug therapy of glaucoma].
    Pfeiffer N.
    Ophthalmologe; 1992 Feb; 89(1):W1-13. PubMed ID: 1349844
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A, Martus P, Schlötzer-Schrehardt U, Langenbucher A, Mardin CY.
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [Abstract] [Full Text] [Related]

  • 33. [The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].
    Ueno R, Yoshida S, Deguchi T, Kato I, Oda T, Hayashi Y, Kuno S.
    Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):462-8. PubMed ID: 1621584
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of topically applied PGF2 alpha and its isopropylester on normal and glaucomatous human eyes.
    Alm A, Villumsen J.
    Prog Clin Biol Res; 1989 Apr; 312():447-58. PubMed ID: 2678150
    [Abstract] [Full Text] [Related]

  • 36. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
    Sharif NA.
    Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 38. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF, Gagliuso DJ, Mittag TW, Podos SM.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [Abstract] [Full Text] [Related]

  • 39. Changing paradigms in the medical treatment of glaucoma.
    Soltau JB, Zimmerman TJ.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S2-5. PubMed ID: 12204696
    [Abstract] [Full Text] [Related]

  • 40. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes.
    Erkiliç K, Ekinciler OF, Mirza GE, Doğan H, Cagil N.
    Int J Clin Pharmacol Res; 1996 Aug; 16(2-3):51-5. PubMed ID: 9063756
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.